ChartRow logo
SNY
Sanofi ADSStock · Health Care
$42.89+$0.11 (+0.26%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

SNY financial statements

The full income statement, balance sheet, and cash-flow statement for Sanofi ADS (SNY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2017-12 1.25B2018-12 1.25B2019-12 1.25B2020-12 1.25B2021-12 1.26B2022-12 1.26B2023-12 1.26B2024-12 1.26B2025-12 1.22B-2.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
38.1B
YoY+13.2%
33.6B
YoY+7.3%
31.4B
YoY+4.0%
30.2B
YoY-5.3%
31.8B
YoY+10.8%
Research & development
8.87B
YoY+10.9%
8.00B
YoY+13.7%
7.04B
YoY+3.0%
6.83B
YoY+1.5%
6.73B
YoY+6.8%
Operating income
7.18B
YoY-8.5%
7.85B
YoY+4.3%
7.53B
YoY-29.5%
10.7B
YoY+11.2%
9.61B
YoY-40.3%
Interest expense
637M
YoY-45.1%
1.16B
YoY-17.0%
1.40B
YoY+209.3%
452M
YoY+3.9%
435M
YoY-1.6%
Income tax
1.18B
YoY-9.4%
1.30B
YoY+18.5%
1.10B
YoY-45.2%
2.01B
YoY+8.9%
1.84B
YoY-10.5%
8.88B
YoY+46.1%
6.08B
YoY+3.4%
5.88B
YoY-34.1%
8.92B
YoY+20.1%
7.43B
YoY-47.2%
$7.21
YoY+50.3%
$4.79
YoY+3.1%
$4.65
YoY-33.6%
$7.00
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
36.4B
YoY-18.1%
44.4B
YoY+30.8%
33.9B
YoY-6.7%
36.4B
149B
YoY+7.5%
139B
YoY-1.1%
140B
YoY+3.6%
135B
YoY-1.1%
137B
YoY-2.6%
Total current liabilities
33.3B
YoY+9.5%
30.4B
YoY+13.5%
26.8B
YoY+4.8%
25.6B
Long-term debt
16.7B
YoY+36.1%
12.3B
YoY-22.6%
15.9B
YoY+0.3%
15.8B
YoY-18.6%
19.5B
YoY-19.6%
83.8B
YoY+3.7%
80.8B
YoY-1.4%
81.9B
YoY+2.8%
79.7B
YoY+2.2%
78.0B
YoY+0.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash from operations
12.2B
YoY+23.8%
9.83B
YoY-11.4%
11.1B
YoY+0.3%
11.1B
YoY-11.1%
12.4B
YoY+47.2%
Acquisitions
0.00
0.00
0.00
0.00
0.00
Long-term debt issued
6.29B
0.00
YoY-100.0%
51.9M
YoY-96.8%
1.63B
0.00
YoY-100.0%
Long-term debt repaid
2.97B
YoY+307.9%
727M
YoY-81.7%
3.98B
YoY+39.4%
2.86B
YoY+7.8%
2.65B
YoY-41.2%
Common stock issued
200M
YoY-1.0%
202M
YoY-4.0%
211M
YoY+6.7%
198M
YoY-10.2%
220M
YoY-4.9%
Common stock repurchased
5.67B
YoY+1636.2%
327M
YoY-49.0%
641M
YoY+22.7%
522M
YoY+15.6%
452M
YoY-51.8%
Dividends paid
5.40B
YoY+6.1%
5.09B
YoY+5.7%
4.82B
YoY+9.9%
4.38B
YoY-7.6%
4.74B
YoY+5.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
59.1B
YoY-3.0%
60.9B
YoY-2.8%
62.7B
YoY+2.5%
61.2B
YoY-3.3%
63.3B
YoY+4.2%
P/E
6.7×
YoY-33.6%
10.0×
YoY+42.5%
7.0×
YoY-14.7%
8.2×
YoY-3.3%
8.5×
YoY+97.1%
P/B
0.7×
YoY-6.5%
0.8×
YoY-4.2%
0.8×
YoY+0.3%
0.8×
YoY-3.3%
0.8×
YoY+3.2%
15.0%
YoY+50.6%
10.0%
YoY-29.8%
14.2%
YoY+17.2%
12.1%
YoY+3.4%
11.7%
YoY-49.3%
9.2%
YoY+8.5%
8.4%
YoY+9.0%
7.7%
YoY+7.1%
7.2%
YoY-4.3%
7.6%
YoY+2.2%
Source filing20-F20-F20-F20-F20-F

About this data

Source: SNY's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SNY filings on SEC EDGAR → Not investment advice.